Not Every Patient With Multiple Sclerosis Should Be Treated at Time of Diagnosis Not Every Patient With Multiple Sclerosis Should Be Treated at Time of Diagnosis2018-01-17T17:05:43-05:00
Clinical Implications of Benign Multiple Sclerosis: A 20-Year Population-Based Follow-up Study Clinical Implications of Benign Multiple Sclerosis: A 20-Year Population-Based Follow-up Study2018-01-17T17:05:43-05:00
Protective and therapeutic role for aB-crystallin in autoimmune demyelination Protective and therapeutic role for aB-crystallin in autoimmune demyelination2018-01-17T17:05:43-05:00
Are low ultraviolet B and high animal protein intake associated with risk of renal cancer? Are low ultraviolet B and high animal protein intake associated with risk of renal cancer?2018-01-17T17:05:43-05:00
Incidence of Multiple Sclerosis among First Nations People in Alberta, Canada Incidence of Multiple Sclerosis among First Nations People in Alberta, Canada2018-01-17T17:05:43-05:00
T Cells of Multiple Sclerosis Patients Target a Common Environmental Peptide that Causes Encephalitis in Mice T Cells of Multiple Sclerosis Patients Target a Common Environmental Peptide that Causes Encephalitis in Mice2018-01-17T17:05:43-05:00
Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis1 Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis12018-01-17T17:05:43-05:00
Is nalalizumab a breakthrough in the treatment of MS? Is nalalizumab a breakthrough in the treatment of MS?2018-01-17T17:05:43-05:00
The Role of Vitamin D in Multiple Sclerosis The Role of Vitamin D in Multiple Sclerosis2018-01-17T17:05:43-05:00
